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Introduction: Lone atrial ﬁbrillation (AF) is deﬁned as AF occurring in the absence of any other
cardiovascular disease. The prognosis of patients with lone AF varies in previous studies, and the
clinical and electroanatomical characteristics of lone AF are unclear. The purpose of this study was to
investigate the clinical characteristics of lone AF.
Methods: This study included 203 patients (52713 years old, 144 males) that underwent circumfer-
ential pulmonary vein isolation (CPVI) for paroxysmal AF. The mean voltage and total activation time of
the individual atria were obtained by using a NavX mapping system and were compared for patients
with lone and non-lone AF. Several parameters, including the age, gender, AF duration, and left atrial
(LA) diameter were analyzed.
Results: Compared with non-lone AF patients, lone AF patients were signiﬁcantly younger (49713
years old vs. 58711 years old, po0.001) and had lower body-mass index (BMI, 24.6072.96 vs.
26.0773.29, p¼0.02), lesser cholesterol level (169.06731.41 vs. 183.63731.12, p¼0.014), smaller
LA diameter (35.8974.90 vs. 40.8674.62, po0.001), and higher LA bipolar voltage (2.1070.50 vs.
1.8370.73 mV, po0.05). Furthermore, a dramatic voltage reduction was observed for 60-year-old
patients.
Conclusion: Patients with lone AF have unique clinical and electroanatomical characteristics.
& 2012 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
Lone atrial ﬁbrillation (AF) was ﬁrst proposed by Evans and
Swann in 1954 [1] and was deﬁned as AF occurring in the absence
of any other clinical evidence suggesting a primary cardiac
disorder or coexisting coronary heart disease, heart failure, rheu-
matic heart disease, or hypertensive cardiovascular disease. The
clinical course of lone AF was studied by Jahangir et al., who
suggested there was a relatively low risk of thromboembolic
complications, heart failure, and mortality [2]. Patients with lone
AF were initially thought to have a normal life expectancy and a
good prognosis [2,3]. However, recent data have revealed differ-
ent results. In the Paris Prospective Study I, idiopathic AF was
associated with a higher mortality in middle-aged Frenchmen
with a long follow-up period [4]. Some other studies showed that
a subgroup of patients with lone AF may have a substantiallyrt Rhythm Society. Published by E
artment of Medicine, Taipei
, Taipei, Taiwan, ROC.
hen).increased risk for thromboembolic events [5,6]. Thus, we asked,
‘‘Does lone AF exist’’? The answer relies on the deﬁnition of lone AF
and on how in-depth one investigates the patient co-morbidities [6].
A previous study demonstrated that abnormal atrial histology
(as a consistent organic substrate) was uniformly distributed in
the interatrial septum of all patients with lone AF [7]. However,
there has been relatively limited information regarding the clinical
characteristics of lone AF. In addition, data on the electroanatomi
cal characteristics of lone AF are sparse. The aim of this study was
to investigate the clinical and electroanatomical characteristics of
patients with paroxysmal lone AF.2. Methods
2.1. Study patients
A total of 203 patients (52713 years old, 144 males), who
received circumferential pulmonary vein isolation (CPVI) for the
treatment of frequent episodes of drug refractory paroxysmal AF
(PAF) with either a history of structural heart disease (non-lone
AF, n¼77) or without (lone AF, n¼126), were enrolled in thislsevier B.V. All rights reserved.
Table 1
Clinical characteristics for lone AF and non-lone AF.
Group characteristic Lone AF (n¼126) Non-lone AF (n¼77) p value
Mean age (years) 49713 58711 o0.001
Males 87 57 NS
AF duration (years) 4.5773.72 3.6572.69 NS
BMI 24.6072.96 26.0773.29 0.02
Left atrial diameter (mm) 35.8974.90 40.8674.62 o0.001
Cholesterol (mg/dl) 169.06731.41 183.63731.12 0.014
Triglycerol (mg/dl) 122.357127.16 134.23766.52 NS
Glucose (mg/dl) 91.09713.90 103.89751.04 0.05
Uric acid (mg/dl) 5.6971.43 5.8971.48 NS
LVEF (%) 6177 6076 NS
LA mean voltage (mV) 2.1070.50 1.8370.73 0.032
RA mean voltage (mV) 2.0470.62 2.1770.71 NS
LA¼ left atrium; RA¼right atrium; LVEF¼ left ventricular ejection fraction;
BMI¼body mass index.
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other clinical evidence suggesting a primary cardiac disorder or
coexisting coronary heart disease, heart failure, rheumatic heart
disease, or hypertension [1,3]. All patients signed the standard
consent form for the electrophysiology study and catheter abla-
tion at Taipei Veterans General Hospital. The retrospective pro-
tocol was approved by the hospital’s Institutional Review Board.
All patients received echocardiography for which the details have
been previously described [8]. The anteroposterior diameter of
the left atrium (LA) at the end-systole was measured by M mode
echocardiography in the parasternal short axis view [9]. Lone AF
was deﬁned as AF occurring in patients without evidence of
cardiopulmonary disease or other secondary causes [1].
2.2. Electrophysiological study and 3-dimensional (3-D) mapping
system
The details of the electrophysiological study and the 3-D map-
ping of AF were described in our previous work [10–16]. Brieﬂy,
each patient underwent an electrophysiological study and catheter
ablation while in the fasting, non-sedated state. All antiarrhythmic
drugs except amiodarone (77 patients) were discontinued for at
least 5 half-lives before the electrophysiological study and ablation
procedure. A 7-French deﬂectable decapolar catheter with a 2-mm
interelectrode distance and 5-mm space between each electrode
pair (Atrial Fibrillation Division, St. Jude Medical, Minnetonka, MN,
USA) was inserted into the coronary sinus via the internal jugular
vein. After the trans-septal procedure, a circular catheter was
positioned into the pulmonary vein.
Bi-atrial electroanatomic maps and sequential contact voltage
maps were constructed for all 203 patients using a 3-D mapping
system (NavX mapping system, Atrial Fibrillation Division, St.
Jude Medical, Minnetonka, MN, USA). The bipolar electrograms
were ﬁltered between 32 and 300 Hz and recorded digitally.
The electrodes of a CS catheter were used to provide a time
reference signal and had to remain in a stable position throughout
the mapping procedure. The absolute peak was selected as the
detection setting to determine the point of activation in the
waveform. A 4-mm tipped ablation catheter (EP Technologies,
Boston Scientiﬁc, MA, USA) was selected as the roving catheter.
The roving signal was used to collect the voltages while the roving
catheter encountered the atrial wall as it was swiped throughout
the atrium during the sinus rhythm (SR). The signal from the roving
catheter was used to build a sequential map. After constructing the
sequential map, the bipolar mapping points were collected and
analyzed using an ofﬂine software [10–16].
2.3. Atrial voltage and surface area analysis
As described in our previous work [12–16], the LA and RA
bipolar peak-to-peak voltages (PPVs) were obtained from more
than 150 sites approximately equally distributed within the atria
before the catheter ablation. The mean PPV throughout the entire
chamber was compared for the lone AF and non-lone AF patients
to investigate any substrate changes.
2.4. Clinical variables
The clinical variables that may inﬂuence the voltage were
analyzed, including the gender, old age (Z60 y/o), obesity [the
body mass index (BMI) Z25 kg/m2, according to the World
Health Organization criterion, was calculated as the weight in
kilograms divided by the square of the height (in meters)], LA
enlargement (LA diameterZ4 cm) [9], and biochemical parameters
such as the blood sugar, cholesterol, triglycerol, and uric acidlevels. The duration of AF was deﬁned as the time from the ﬁrst
AF attack to the date of the ablation procedure.
2.5. Statistical analysis
The values for each patient are reported as the mean7standard
deviation (SD). A chi-square test with a Yates’ Correction or Fisher’s
Exact Test was used for categorical data. A paired-sample t test was
used for the continuous data. A univariate analysis of the various
clinical variables (i.e., age, sex, BMI, atrial size, and serum cholesterol
level) was performed to determine the predictors of the mean
voltage during SR. The variables selected for testing in the multi-
variate analysis were those with a po0.1 in the univariate model.
A value po0.05 was considered to be statistically signiﬁcant.3. Results
3.1. Characteristics of patients with and without structural heart
disease
The baseline characteristics of all patients with lone AF
(n¼126, 87 males) and non-lone AF (n¼77, 57 males) are listed
in Table 1. The mean duration of the AF, triglycerol, and uric acid
levels, as well as the left ventricular ejection fraction (LVEF), were
similar for the lone AF and non-lone AF groups. Four clinical
parameters differed between the 2 groups. First, the mean age of
the lone AF group was signiﬁcantly lower than that of the non-
lone AF group (49713 vs. 58711 years old, po0.001). Second,
the BMI (24.6172.96 vs. 26.0773.29, p¼0.02) and cholesterol
serum level (169.06731.41 vs. 183.63731.12, p¼0.014) were
lower for the lone AF patients compared with the non-lone AF
patients (Table 1). Third, the LA diameter was smaller for the
lone AF group compared with that for the non-lone AF group
(35.8974.90 vs. 40.8674.62 mm, po0.001), and the blood sugar
level was somewhat lower in the patients with lone AF than in
patients with non-lone AF (borderline signiﬁcance, p¼0.05,
Table 1). For the non-lone AF group, 61 patients had a history of
hypertension, 15 patients had a history of coronary artery disease,
3 patients had a history of heart failure, and 4 patients had
valvular heart disease (VHD).
3.2. The electroanatomic properties of the RA and LA substrate
The mean bipolar PPV of the LA was lower in patients with
non-lone AF than in patients with lone AF (1.8370.73 vs.
2.1070.50 mV, po0.05) (Table 1 and Fig. 1). However, the mean
bipolar PPV of the RA (mapping sites¼2507108 points) was
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(Table 1 and Fig. 1). To evaluate the effect of age on the LA
substrate, we divided the patients into 4 groups according to theirTable 2
Clinical variables affecting the left atrial substrate.
Characteristic Group LA voltage in lone AF
(mV, mean7SD, n¼126
BMI o25 2.0470.46
Z25 2.1570.57
LAE Yes (Z40 mm) 1.9170.62
No (o40 mm) 2.1470.49
Age Z60 years 1.7870.33
o60 years 2.1870.51
Gender Female 2.0770.63
Male 2.1170.43
Cholesterol Z200 mg/dl 2.1670.41
o200 mg/dl 2.0870.49
BMI¼body mass index; LAE¼ left atrial enlargement.
n pr0.05 vs. the lone AF group.
Fig. 2. The inﬂuence of the age of the patients with lone AF. To evaluate the effect
of age, the patients were divided into 4 groups based on their age: o40 (n¼28),
40–49 (n¼32), 50–59 (n¼43) and Z60 (n¼23). The mean bipolar PPVs for these
groups are presented as the mean7SD. The voltage was dramatically reduced for
patients older than 60 years (po0.005) compared with the other groups.
Fig. 1. The mean bipolar PPV of the LA was lower in patients with (n¼77) a
previous history of structural heart disease than in patients without (n¼126) a
history of structural heart disease (1.8370.73 vs. 2.1070.50 mV, po0.05). There
was no difference in the RA (2.770.17 vs. 2.0470.62 mV, p¼NS).age: o40, 40–49, 50–59, and Z60. The mean bipolar PPVs for
these groups are shown in Fig. 2. There was a signiﬁcant voltage
reduction when the age was over 60 (po0.005).
3.3. Effect of the clinical variables on the left atrial substrate
The clinical manifestations that affect the LA voltages observed
for the lone AF and non-lone AF patients are shown in Table 2. The
clinical variables that may affect the LA substrate were analyzed, and
the results showed that these variables were not inﬂuenced by any of
the clinical variables of the patients with non-lone AF. However, for
the lone AF group, mean LA voltage of patients older than 60 years
was signiﬁcantly lower than that of patients younger than 60 years
(po0.05, Table 2). Subgroup analysis between the lone AF and non-
lone AF patient groups was also performed. This analysis revealed
that the BMI (either Z25 or o25) and LA enlargement (Z40 or
o40) did not signiﬁcantly inﬂuence the LA substrate. In contrast, the
LA voltage was signiﬁcantly higher in the lone AF group compared
with that in the non-lone AF group for patients younger than 60
years (2.1870.51 vs. 1.8170.73 mV, po0.05), and there was no
signiﬁcant difference for patients older than 60 years. Interestingly,
among male patients, LA mean voltage of patients in the lone AF
group was higher than that of patients in the non-lone AF group
(2.1170.43 vs. 1.8170.74, po0.05); however, no difference was
observed among the females (2.0770.63 vs. 1.8970.72, p¼NS).
Further analyses of the clinical manifestations on the effect of the LA
voltage among the non-lone AF patients are shown in Table 3. No
factors affected the mean bipolar RA PPV for the patients with non-
lone AF. However, patients with VHD had a signiﬁcantly lower LA
mean voltage compared with patients without VHD (0.9570.51 vs.
1.8970.71 mV, p¼0.033). Surprisingly, patients with hypertension
had a signiﬁcantly higher LA voltage compared with patients without
hypertension (2.0570.66 vs. 1.0370.32 mV, po0.001).
3.3.1. Multivariate analysis
The clinical variables that may inﬂuence the voltage time were
analyzed. Multivariate analysis showed that only age Z60 years
was an independent factor for determining the value of the mean
voltage in the LA (p¼0.007).4. Discussion
4.1. Main ﬁndings
The patients with lone AF had unique clinical and electro-
anatomical characteristics. We found that the lone AF group was)
p value LA voltage in non-lone AF
(mV, mean7SD, n¼77)
p value
0.398 1.7570.11 0.471
1.9370.72
0.158 1.6970.75 0.371
1.9270.71
0.005 1.8570.74 0.848
1.8170.73n
0.788 1.8970.72 0.756
1.8170.74n
0.706 1.6270.65 0.354
1.9270.81
Table 3
Clinical variables affecting the atrial substrate for patients with non-lone AF.
Characteristic Group RA voltage (mV, mean7SD) p value LA voltage (mV, mean7SD) p value
BMI o25 (n¼32) 2.1470.84 0.725 1.7570.11 0.471
Z25 (n¼45) 2.2370.68 1.9370.72
LAE Yes (Z40 mm, n¼40) 2.1070.64 0.562 1.6970.75 0.371
No (o40 mm, n¼37) 2.2370.82 1.9270.71
Age Z60 years (n¼31) 2.0770.65 0.501 1.8570.74 0.848
o60 years (n¼46) 2.2370.76 1.8170.73
Gender Female (n¼20) 2.0470.81 0.532 1.8970.72 0.756
Male (n¼57) 2.2170.69 1.8170.74
Cholesterol Z200 mg/dl (n¼34) 2.4470.74 0.442 1.6270.65 0.354
o200 mg/dl (n¼43) 2.0870.49 1.9270.81
Hypertension Yes (n¼61) 2.2870.70 0.120 2.0570.66 0.000
No (n¼16) 1.8570.71 1.0370.32
CAD Yes (n¼15) 2.3070.79 0.619 1.9570.82 0.701
No (n¼62) 2.1670.71 1.8470.64
VHD Yes (n¼4) 1.9371.21 0.657 0.9570.51 0.033
No (n¼73) 2.1870.70 1.8970.71
BMI¼body mass index; LAE¼ left atrial enlargement; CAD¼coronary artery disease, VHD¼valvular heart disease.
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smaller LA diameter compared with patients with non-lone AF.
Furthermore, the mean bipolar PPV of the LA was lower for patients
with non-lone AF than for patients with lone AF; however, there was
a similar mean bipolar PPV of the RA. Furthermore, there was a
signiﬁcant voltage reduction when the patients were older than
60 years.
4.2. Prior studies of lone AF
AF is the most common tachyarrhythmia in clinical practice
[17,18] and the prevalence increases signiﬁcantly with age. Lone
AF is a speciﬁc subtype deﬁned as AF occurring in patients
without any evidence of cardiopulmonary disease or other sec-
ondary causes. A wide prevalence range for lone AF (1.6–11.4%)
has been reported [3,19,20]. Several risk factors for lone AF have
been studied, including obesity [21], socioeconomic status [22],
alcohol consumption [23], sports activity [24], and sleep apnea
syndrome [25]. Epidemiological data show a male predominance
among patients with lone AF [2], which has been subsequently
conﬁrmed by a study on possible familial probands [26].
Initially, lone AF was thought to be a benign disease with
a good prognosis and a lower risk for adverse events [2,27].
Interestingly, the subgroup patients originally diagnosed with
lone AF may have a worse prognosis based on their LA volume,
age, or subtype of lone AF (i.e., paroxysmal or chronic) [2,5,6].
Therefore, lone AF may not always be benign, and some unknown
factors may inﬂuence the prognosis of lone AF.
4.3. Atrial substrates of lone AF
There have been few studies addressing the clinical and electro-
anatomical characteristics of lone AF. In the present study, unique
clinical characteristics were that the patients with lone AF were
signiﬁcantly younger and had a lower BMI, serum cholesterol level,
and a smaller LA size compared with the patients with non-lone AF.
Interestingly, some discordance between the LA and RA substrates
was noted. The mean bipolar PPV of the LA (but not the RA) was
signiﬁcantly lower in patients with non-lone AF compared with those
with lone AF. Why did this difference exist? Gottdiener et al. reported
that hypertension and obesity are both related to an enlarged LA [28],
which could contribute to the heterogeneity of the LA. Our previous
studies have already demonstrated that the LA size signiﬁcantly
inﬂuences the LA mean voltage and the long-term outcome afterCPVI. Furthermore, the LA has a lower voltage, a higher heterogeneity
of the LA voltage, a greater low-voltage zone, and a greater scar area
index compared with the RA in the patients with AF [29,30]. In our
patient group, the non-lone AF patients had signiﬁcant underlying
diseases, including hypertension and obesity, and a larger LA com-
pared with the lone AF patients. This may further explain the
discordance between the LA and RA in the patients with paroxysmal
lone AF.
An interesting ﬁnding was that compared to the male patients
in the non-lone AF group, the male patients in the lone AF group
had a higher LA mean voltage, but no difference was observed
among female patients. A possible mechanismmay due to the lower
cardiovascular co-morbidity of pre-menopause women. More car-
diovascular co-morbidities lead to greater diffuse atriopathy, an
enlarged atrium, and further promote atrial ﬁbrosis [31–33]. There-
fore, the effect of structural heart disease on the atrial voltage may
be compensated by pre-menopause women.
4.4. Limitations
First, this is a retrospective study with observational data. The
underlying causes of our ﬁndings may be difﬁcult to explain in the
current study. Second, the deﬁnition of non-lone AF patients in this
study was only based on previous publications. The information of
relevant cardiac structural changes or contributory cardiovascular
problems was not included; the inclusion of these factors may alter
the results. However, the number of cases with severe structural
changes was relatively small in our study, perhaps explaining why
the duration of the PAF and LVEF are similar for lone PAF and non-
lone PAF patients. In addition, AF persistency is an important factor
for atrial ﬁbrosis. Persistent AF patients are included in the lone AF
registry as epidemiological data, but these data are not included in
our study. Third, we only evaluated the LA diameters; we did not
determine the LA volume by 3-D computer tomography because
these data were not always available. Further studies may be required
to investigate this issue. Finally, we did not perform a subarea
analysis of the LA voltages. However, we obtained LA voltages equally
distributed in the atria.5. Conclusion
For the patients with paroxysmal lone AF, 4 clinical para-
meters were different from the non-lone AF patients, including
T.-C. Tuan et al. / Journal of Arrhythmia 28 (2012) 182–186186the age, BMI, LA size, and total cholesterol level. The mean bipolar
voltage was signiﬁcantly lower in patients with non-lone AF
compared with that in patients with lone AF. The mean bipolar
voltage was also signiﬁcantly reduced in patients older than 60
years. Therefore, the patients with lone AF have unique clinical
and electroanatomical characteristics.Acknowledgements
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